World News: 17:43 GMT Wednesday 15th May 2019. [Reports And Data via Globe Newswire via SPi World News]
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- The Antibody production market is expected to reach USD 26.16 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the increasing prevalence of contagious diseases globally, coupled with the expanding demand for protein therapeutics, which is promoting the development of the global market. The clinical and commercial progress of monoclonal antibodies has resulted in the need for production of antibodies in mammalian cell culture on a large-scale. Based on statistics, the rise in targeted immunotherapy adoption along with enhanced acceptance by regulatory authorities for therapeutic antibodies and an increase in R&D investment of biotechnology and pharmaceutical companies stimulate the growth of the global market. Also, the rise in the prevalence of infectious diseases and growth in demand for protein therapeutics is expected to spur the market growth further. However , expensive primary antibodies will restrain the growth.
Antibodies also acknowledged as immunoglobulins, are abundant Y-shaped proteins that are generated by plasma cells, and are utilized by the immune system to neutralize pathogens such as viruses and bacteria. The immune system responds to external materials or antigens penetrating inside the body by producing antibodies. The two main types of antibodies are polyclonal and monoclonal antibodies, which can also be produced by techniques like hybridoma. The natural ability to create antibodies that can connect antigens can be used in the manufacturing of probes to identify distinct molecules of interest across a wide spectrum of diagnostic applications and research.
Till date, no other technology offers researchers scope for designing and manufacturing such highly useful molecular recognition tools.
North America accounts for the largest market share of 32.3% in 2018. This region is anticipated to grow significantly during the forecast period because of the presence of several leading biopharmaceuticals and biotechnology companies. The market growth is further spurred due to the increasing incidences of cancer, government expenditures, and the growing demand for quality cancer therapy.
For the purpose of this study, Reports and Data have segmented the global Antibody production market on the basis of Class, End-User, Process and Region:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports And Data | Web:
Direct Line: +1-800-819-3052
Globe Newswire: 17:43 GMT Wednesday 15th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.